# Sumatriptan

## Imigran FDT 50mg

| 藥物代碼 | OIMI5 |
| :--- | :--- |
| 適應症 | Acute relief of migraine attacks with or without aura. |
| 副作用 | Tingling, dizziness, drowsiness; transient increase in BP, flushing, nausea & vomiting; sensations of heaviness, heat, pressure or tightness; pain, feelings of weakness, fatigue. |
| 禁忌 | Previous MI, ischaemic heart disease \(IHD\), Prinzmetal's angina/coronary vasospasm, peripheral vascular disease or patients who have symptoms or signs consistent with IHD; history of previous CVA or transient ischaemic attack \(TIA\); uncontrolled HTN; severe hepatic impairment. Concomitant use of ergotamine or its derivatives \(including methysergide\), MAOIs or use within 2 wk of MAOI therapy. |
| 藥物保存方式 | 室溫 |
| 用法用量 | Tab/FDT tab Adult 50-100 mg. Further doses may be given in the next 24 hr provided not &gt; 300 mg is taken in any 24-hr period. |
| 肝功能異常 | 需 調 整 劑 量  輕度到中度肝功能不全病患建議 MAX single dose 50 mg orally |
| 腎功能異常 | 無需調整劑量 |
| 懷孕用藥危分級 | 除非治療上需要 |
| 孕期用藥建議 | No \(Limited\) Human Data - animal data suggest moderate risk |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | No \(Limited\) Human Data - Probably Compatible 無\(很少\)資料 - 可使用 |
| 附帶說明 | N/A |
| 注射劑給藥建議途徑 | N/A |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | N/A |

